Bizily Scott's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Aug 17, 2026
- Accession no.
- 0001193125-26-354313
- Filed
- Aug 17, 2026, 5:34 PM ET
- Trade date
- Aug 13-17, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $39.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bizily ScottCIK 0001920738 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseAcquired | +1,635 | $4.14 | +$6,768.9 | 10,252 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −1,635 | $12.00 | −$19,620 | 8,617 | Direct | |
| Aug 17, 2026 | Common Stock | MOption exerciseAcquired | +1,635 | $4.14 | +$6,768.9 | 10,252 | Direct | |
| Aug 17, 2026 | Common Stock | SSaleDisposed | −1,635 | $12.20 | −$19,947 | 8,617 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseDisposed | −1,635 | $0.00 | $0 | 61,336 | Direct | |
| Aug 17, 2026 | Common Stock | MOption exerciseDisposed | −1,635 | $0.00 | $0 | 59,701 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.